New biotransformation pathways from sulfamethoxazole and ciprofloxacin removal in sewage treatment along the spatial profile of an anaerobic fixed bed bioreactor

• Published in: Bioresource technology reports 2022-02, Vol.17, p.100944, Article 100944
• Main Authors: Carneiro, Rodrigo B., Sabatini, Carolina A., Titato, Guilherme M., Ferreira, Tanare C.R., Zaiat, Marcelo, Santos-Neto, Álvaro J.
• Format: Article
• Language: English
• Subjects: Anaerobic packed bed biofilm reactor; Antibiotics; Fluoroquinolone; Metabolite; Sulfonamide
• ISSN: 2589-014X; 2589-014X
• DOI: 10.1016/j.biteb.2022.100944

In this work, the biotransformation products (BTPs) from the removal of the antibiotics sulfamethoxazole (SMX) and ciprofloxacin (CIP) were assessed for the first time in an anaerobic packed bed biofilm reactor (APBBR) treating municipal sewage. Anaerobic batch assays at high concentrations of the antibiotics (5 mg·L−1) were performed to identify the BTPs generated during the SMX and CIP biodegradation. From the mass transitions of the identified BTPs, they were analyzed along the spatial profile of the APBBR fed with sewage (400 ngSMX·L−1 and 300 ngCIP·L−1). Three BTPs were identified: m/z 256 and m/z 270 from SMX, and m/z 316 from CIP. The molecular structures of the BTPs revealed that SMX biotransformation occurs in the isoxazole ring and a dehydroxylation in the CIP molecule. This study showed new biotransformation pathways of SMX and CIP during anaerobic digestion, contributing to the understanding of the fate of these pharmaceutical compounds in the environment. [Display omitted] •The molecules of SMX and CIP were biotransformed during the anaerobic digestion.•SMX and CIP metabolites were assessed in an anaerobic fixed bed reactor.•The sulfonamide presented a cleavage in the isoxazole ring.•A dehydroxylation was observed in the CIP molecule.•New anaerobic biotransformation pathways of SMX and CIP were found.